Achieve Life Sciences Inc (ACHV)
3.07 x 2 3.75 x 2
Post-market by (Cboe BZX)
3.07 +0.22 (+7.72%) 01/22/25 [NASDAQ]
3.07 x 2 3.75 x 2
Post-market 3.49 +0.42 (+13.68%) 16:02 ET
for Wed, Jan 22nd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 12,466 | 8,431 | 5,982 | 4,386 | 6,572 |
Operating Income | -12,466 | -8,431 | -5,982 | -4,386 | -6,572 |
Interest Expense | 366 | 804 | 813 | 787 | 781 |
Other Income | 320 | 774 | 301 | -303 | 245 |
Pre-tax Income | -12,512 | -8,461 | -6,494 | -5,476 | -7,108 |
Net Income Continuous | -12,512 | -8,461 | -6,494 | -5,476 | -7,108 |
Net Income | $-12,512 | $-8,461 | $-6,494 | $-5,476 | $-7,108 |
EPS Basic Total Ops | -0.36 | -0.25 | -0.26 | -0.23 | -0.34 |
EPS Basic Continuous Ops | -0.36 | -0.25 | -0.26 | -0.23 | -0.34 |
EPS Diluted Total Ops | -0.36 | -0.25 | -0.26 | -0.23 | -0.34 |
EPS Diluted Continuous Ops | -0.36 | -0.25 | -0.26 | -0.23 | -0.34 |
EPS Diluted Before Non-Recurring Items | -0.36 | -0.25 | -0.26 | -0.26 | -0.34 |
EBITDA(a) | $-12,400 | $-8,374 | $-5,925 | $-4,329 | $-6,514 |